Macquarie Group LTD Merrimack Pharmaceuticals Inc Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 15, 2019	SELL	$3.19 - $5.73 $5,104 - $9,168	-1,600 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$2.95 - $4.15 $4,720 - $6,640	1,600 New	1,600 $6,000
Q2 2018 Aug 14, 2018	SELL	$3.86 - $7.61 $68,823 - $135,686	-17,830 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$6.24 - $9.15 $39,312 - $57,645	-6,300 Reduced 26.11%	17,830 $144,000
Q4 2017 Feb 15, 2018	BUY	$7.99 - $11.87 $117,453 - $174,489	14,700 Added 155.89%	24,130 $247,000
Q3 2017 Nov 08, 2017	BUY	$9.13 - $11.72 $86,095 - $110,519	9,430	9,430 $137,000

Others Institutions Holding MACK

# of Institutions

1

Shares Held

77

Call Options Held

0

Put Options Held

0

Farther Finance Advisors, LLC San Francisco, CA

77
Shares

$1,165
0.0% of portfolio

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.